Model | Convergence diagnostics | Goodness of fit (deviance) [SE] | Vaccine effectiveness (%) [95% BCI] | |||
---|---|---|---|---|---|---|
Maximum \(\widehat{\text{R}}\) | LOO-CV | WAIC | 1 dose | 2 doses | 3 doses | |
NB1 | 1.00101 | 622.4 [28.8] | 619.6 [28.4] | 33.7 [13.2; 50.4] | 78.7 [71.3; 84.3] | 80.1 [70.4; 86.6] |
P1 | 1.00004 | 622.6 [28.8] | 619.9 [28.4] | 33.5 [12.4; 49.7] | 78.7 [71.5; 84.5] | 80.1 [70.3; 86.7] |
P2 | 1.00003 | 622.9 [29.1] | 620.2 [28.7] | 34.1 [13.4; 50.4] | 78.9 [71.6; 84.4] | 80.4 [70.5; 86.9] |
NB2 | 1.00032 | 623.1 [29.1] | 620.3 [28.7] | 33.9 [12.7; 49.8] | 78.9 [71.7; 84.5] | 80.4 [70.7; 87.0] |
NB3 | 1.00008 | 646.2 [27.0] | 645.1 [26.9] | 31.9 [7.7; 49.9] | 76.0 [66.2; 83.2] | 78.5 [66.7; 86.2] |
P3 | 1.00005 | 671.3 [35.3] | 669.7 [35.2] | 31.1 [10.0; 47.3] | 77.8 [70.5; 83.5] | 78.9 [68.8; 85.9] |
NB4 | 1.00052 | 675 [26.9] | 633.1 [23.7] | 21.1 [− 6.8; 41.7] | 72.0 [60.7; 80.5] | 76.2 [62.7; 85.2] |
P4 | 1.00012 | 676.6 [27] | 633 [23.7] | 21.0 [− 6.6; 42.3] | 71.9 [59.8; 80.2] | 76.2 [62.2; 85.0] |
P5 | 1.00011 | 706.3 [25.9] | 641.8 [22.9] | 25.6 [− 6.0; 47.7] | 72.3 [58.8; 81.8] | 75.0 [58.3; 85.4] |
NB5 | 1.00038 | 707.1 [26] | 642 [22.9] | 25.8 [− 5.5; 48.6] | 72.4 [58.2; 81.3] | 74.9 [57.3; 85.2] |